News Wire
Study: C-Section Babies Run Increased Risk of Developing Food Allergies
Data shows children born by C-section run a 21% higher risk of developing food allergies than children born by vaginal delivery.
Viaskin Peanut Completes Phase III Part A Study of Toddlers With No Safety Concerns
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.
Not Just Ticks: Allergists Warn that Chigger Bites May Cause Allergic Reaction to Red...
In addition to being uncomfortable and annoying, their bites may also cause alpha-gal.
Study: Fewer Than Half Use Their Epinephrine Auto-Injector Before Arriving at ER with Anaphylaxis
“It’s a disappointing reality that epinephrine is seriously underused.”
Company Developing Peanut Immunotherapy Toothpaste Meets with FDA
"INT301 has the potential to be the first allergy immunotherapy treatment that easily integrates into a person’s daily routine."
Study: Children with Food Allergy at Lower Risk for Complicated Appendicitis
Children with allergies may have a lower risk because their immunological response is different from that of non-allergic children.
FDA Grants Fast Track Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis
"A significant milestone for INSYS and our clinical development of this novel drug-device combination.”
In Response to Shortage, AUVI-Q® Will Be Available in Canada Starting September 7
Interim order by Minister of Health authorizes the importation and sale.
EAT Launches ‘Give and Go’ Public Service Announcement
PSA will air in movie theaters and online to promote action when anaphylactic reactions occur.
Pfizer Issues Statement Extending the Expiration Date for Select Lots of EpiPen
To address shortages of EpiPen, Pfizer is coordinating with FDA to extend the expiration dates of specific lots of EpiPen® 0.3 mg Auto-Injectors.
